ARDSLEY ADVISORY PARTNERS LP - CORREVIO PHARMA CORP ownership

CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 40 filers reported holding CORREVIO PHARMA CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
ARDSLEY ADVISORY PARTNERS LP ownership history of CORREVIO PHARMA CORP
ValueSharesWeighting
Q3 2019$25,000
-7.4%
12,5000.0%0.01%
+50.0%
Q2 2019$27,000
-18.2%
12,500
+20.6%
0.00%
-33.3%
Q1 2019$33,00010,3660.01%
Other shareholders

There were no reported owners of CORREVIO PHARMA CORP in Q3 2019.

NameSharesValueWeighting ↓
View complete list of CORREVIO PHARMA CORP shareholders